VAGINAL ADENOCARCINOMA
Clinical trials for VAGINAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VAGINAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for VAGINAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a drug combo boost survival in advanced cervical cancer?
Disease control OngoingThis study tests whether adding the drug triapine to standard radiation and chemotherapy (cisplatin) helps women with advanced cervical or vaginal cancer live longer. About 450 women with newly diagnosed, bulky stage IB2 to IVA cervical cancer or stage II-IVA vaginal cancer will …
Matched conditions: VAGINAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 13:07 UTC
-
Immunotherapy duo takes on 50+ rare cancers in major trial
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) in over 800 people with more than 50 types of rare cancers. The goal is to see if this treatment can shrink tumors by helping the immune system attack cancer cells. The study is for patie…
Matched conditions: VAGINAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC